Buradasınız

SELF-EMULSIFYING DRUG DELIVERY SYSTEM: A REVIEW OF THEIR APPLICABILITY IN DRUG DELIVERY TECHNOLOGIES

Journal Name:

Publication Year:

Abstract (2. Language): 
Around 40% of novel chemical entities show evidence of poor aqueous solubility due to their low bioavailability. Selfemulsifying drug delivery systems (SEDDS) have gain exposure to improve the bioavailability of hydrophobic drugs. SEDDSs are belongs to lipid formulations, and size range is from100nm (SEDDs) to less than 50nm (SMEDDs) and contains a isotropic mixtures of oils, surfactants, and co-surfactants, which are emulsified in aqueous media under conditions of gentle stirring. The theory behind dissolution rate improvement by means of SEDDS is the spontaneous development of the emulsion in the gastrointestinal tract with mild agitation provided by gastric mobility, which presents the drug in solubilized form, and the small size of the formed droplet provides a large interfacial surface area for drug absorption. Due to its small globule size, the micro/nanoemulsifed drug can easily be absorbed through lymphatic pathways, thereby bypassing the hepatic first-pass effect. This article gives in overview of SEDDS with emphasis on different types of self-emulsifying formulation, characterization, application, advantages and recent development.
785
790

REFERENCES

References: 

1. Jessy Shaji, Digambar Jadhav, “Newer Approches To
Self Emulsifying Drug Delivery System”
International Journal Of Pharmacy And
Pharmaceutical Sciences Vol 2, Suppl 1, 2010, 37-
42
2. Wakerly, M.G., Pouton, C.W., Meakin, B.J., Morton,
F.S., 1986. Self emulsification of vegetable oil-nonionic
surfactant mixtures. Am ChemSocSymp
Series. 311, 242–255.
3. Kommuru, T.R., Gurley, B., Khan, M.A., Reddy, I.K.,
2001. Self-emulsifying drug delivery systems
(SEDDS) of coenzyme Q10: Formulation
development and bioavailability assessment. Int J
Pharm. 212, 233–246.).
4. Charman, S.A., Charman, W.N., Rogge, M.C., 1992.
Self-emulsifing drug delivery systems: formulation
and evaluation of an investigational lipophilic
compound. Pharm Res. 9, 87-93.
5. Pouton, C.W., 1997. Formulation of self-emulsifying
drug delivery systems. Adv Drug Deliv Rev. 25, 47-
58.
6. Klauser, R.M., Irshik, H., Kletzmayr, J., Sturm, I.,
Brunner, W., Woloszczuk, W., 1997.
Pharmacokinetic cyclosporine a profiles under
long-term neoral treatment in renal transplant
recipients: does fat intake still matter? Transplant
Proc. 29, 3137– 3140.
7. Khoo, S.M., Humberstone, A.J., Porter, C.J.H.,
Edwards, G.A., Charman, W.N., 1998. Formulation
design and bioavailability assessment of lipidic
self-emulsifying formulations of halofantrine. Int J
Pharm. 167,155–164.
8. Jayaraj, A.A., Keirns, J.J. 1998. Lipid-based delivery
systems for improving the bioavailability and
lymphatic transport of a poorly water soluble LTB4
inhibitor. J Pharm Sci. 87,164–169.
9. Solomon, L.J., Seager, H., Pouton, C.W., 1997.
Influence of lipolysis on drug absorption from the
gastrointestinal tract. Adv Drug Deliv Rev. 25, 33–
46.
10. Porter, C.J.H., Kaukonen, A.M., Boyd, B., Edwards,
G.A., Charman, W. N., 2004. Susceptibility to lipasemediated
digestion reduces the oral bioavailability
of danazol after administration as a medium chain
lipid based microemulsion formulation. Pharm Res.
21, 1405-1412.
11. Patel M. J., Patel, S. S., Patel M. N., Patel, M. M., 2010.
A self-microemulsifying drug delivery system
(SMEDDS). Int J Pharm Sci Rev Res. 3, 29-33.
12. Arijit Gandhi &Parimal Maji1, Self-emulsifying drug
delivery system: an approach for enhancement of
bioavailability of poorly water soluble drugs,
International Journal of Pharmacy and Integrated
Life Sciences V1-(I6) 1-16.
13. Pallavi M. et al “self emulsifying drug delivery
system (sedds): a review” IJPBS volume 2, issue 2,
April- June, 2012, 42-52.
14. Constantinides, P.P., 1995. Lipid microemulsions
for improving drug dissolution and oral
absorption: Physical and biopharmaceutical
aspects. Pharm Res. 12, 1561–1572

Thank you for copying data from http://www.arastirmax.com